Suppr超能文献

肝门部胆管癌

Hilar cholangiocarcinoma.

作者信息

Zaydfudim Victor M, Rosen Charles B, Nagorney David M

机构信息

Department of Surgery, University of Virginia, 1300 Jefferson Park Avenue, Charlottesville, VA 22908, USA.

Division of Transplantation Surgery, Mayo Clinic, 200 1st Street Southwest, Rochester, MN 55905, USA.

出版信息

Surg Oncol Clin N Am. 2014 Apr;23(2):247-63. doi: 10.1016/j.soc.2013.10.005.

Abstract

Optimal treatment of hilar cholangiocarcinoma depends on location of the cancer and extent of biliary and vascular involvement. Candidates for resection or transplantation must be evaluated and managed by a multidisciplinary team at a high-volume hepatobiliary center. Success requires absence of distant nodal or extrahepatic metastases and an adequate functional liver remnant with a negative ductal margin. Ipsilateral portal vein resection and reconstruction should be performed in patients with venous involvement. Neoadjuvant chemoradiation and liver transplantation is the best treatment option for patients with unresectable hilar cholangiocarcinoma without nodal or distant metastases and for patients with underlying chronic liver disease.

摘要

肝门部胆管癌的最佳治疗方法取决于癌症的位置以及胆管和血管受累的程度。进行切除或移植的患者必须由大容量肝胆中心的多学科团队进行评估和管理。成功的关键在于无远处淋巴结或肝外转移,以及有足够功能的肝残余且切缘胆管阴性。对于有静脉受累的患者,应进行同侧门静脉切除和重建。新辅助放化疗和肝移植是无法切除的无淋巴结或远处转移的肝门部胆管癌患者以及伴有潜在慢性肝病患者的最佳治疗选择。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验